Application of CRISPR/Cas9 gene editing technique in the study of cancer treatment. Issue 1 (10th July 2019)

• Record Type: Journal Article
• Authors: Jiang, Chunyang; Meng, Lingxiang; Yang, Bingjun; Luo, Xin
• Is Part Of: Clinical genetics. Volume 97:Issue 1(2020)
• Page Start: 73
• Page End: 88
• Publication Date: 2019-07-10
• Subjects: Cancer -- CRISPR/Cas9 -- gene editing -- therapy; Medical genetics -- Periodicals; 616.0420
• DOI: 10.1111/cge.13589
• Languages: English
• ISSNs: 0009-9163

Abstract

Abstract: In recent years, gene editing, especially that using clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9, has made great progress in the field of gene function. Rapid development of gene editing techniques has contributed to their significance in the field of medicine. Because the CRISPR/Cas9 gene editing tool is not only powerful but also has features such as strong specificity and high efficiency, it can accurately and rapidly screen the whole genome, facilitating the administration of gene therapy for specific diseases. In the field of tumor research, CRISPR/Cas9 can be used to edit genomes to explore the mechanisms of tumor occurrence, development, and metastasis. In these years, this system has been increasingly applied in tumor treatment research. CRISPR/Cas9 can be used to treat tumors by repairing mutations or knocking out specific genes. To date, numerous preliminary studies have been conducted on tumor treatment in related fields. CRISPR/Cas9 holds great promise for gene‐level tumor treatment. Personalized and targeted therapy based on CRISPR/Cas9 will possibly shape the development of tumor therapy in the future. In this study, we review the findings of CRISPR/Cas9 for tumor treatment research to provide references for related future studies on the pathogenesis and clinical treatment of tumors. Abstract : Using CRISP/Cas9 in the study of tumor therapies.